Artiva Biotherapeutics lands $78m Series A

San Diego-based Artiva Biotherapeutics, Inc., an oncology company, has raised $78 million in Series A financing.

29 June 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles